Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs OKYO Pharma Limited Sponsored ADR (OKYO)

Coya Therapeutics, Inc. and OKYO Pharma Limited Sponsored ADR are both Biotechnology companies. Coya Therapeutics, Inc. and OKYO Pharma Limited Sponsored ADR are of similar size ($75.1M and $72.3M). OKYO Pharma Limited Sponsored ADR has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 12 metrics below, OKYO Pharma Limited Sponsored ADR leads on 7 and Coya Therapeutics, Inc. on 5.

Valuation

Metric COYA OKYO Biotechnology median
P/E n/m n/m 10.26
P/S 8.25 n/m 9.18
P/B 1.53 85.82 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 4.48 n/m 8.98
Earnings yield (37.94%) 0.00% (34.89%)
Free cash flow yield (26.87%) (0.90%) (24.52%)

Profitability

Metric COYA OKYO Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (288.70%) — 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) 0.00% (50.12%)
Return on assets (53.66%) 0.00% (45.60%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA OKYO Biotechnology median
Revenue growth (TTM) 108.35% — 6.26%
EPS growth (last fiscal year) (29.59%) (101.34%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA OKYO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 2.43 4.89
Net debt to EBITDA 2.08 2.42 1.01

Dividend

Metric COYA OKYO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COYA OKYO Biotechnology median
Market cap 72.25m 75.05m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack